Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture

Manjunath Supriya1, Rita Christopher2, Bhagavatula Indira Devi3

  • 1Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences(NIMHANS), Bengaluru, 560029, India.

Abstract

Insights

Researchers identified eight plasma microRNAs (miRNAs) that can serve as biomarkers for ruptured intracranial aneurysms (IAs). These specific miRNA signatures distinguish patients with aneurysmal subarachnoid hemorrhage (aSAH) from healthy individuals, offering potential diagnostic tools.

Area of Science:

  • Biochemistry
  • Genetics
  • Neuroscience

Background:

  • Diagnosis of ruptured intracranial aneurysms (IAs) relies on advanced neuro-imaging.
  • Currently, no molecular biomarkers exist to identify IAs or predict their rupture.

Purpose of the Study:

  • To determine plasma microRNA (miRNA) expression profiles in patients with aneurysmal subarachnoid hemorrhage (aSAH).
  • To identify potential miRNA biomarkers for aneurysmal rupture.

Main Methods:

  • Plasma miRNA profiling using quantitative real-time polymerase chain reaction (qRT-PCR) in aSAH patients and healthy controls.
  • Validation of differentially expressed miRNAs in a larger cohort.
  • Receiver operating characteristic (ROC) curve analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.

Main Results:

  • Distinct miRNA profiles were observed between aSAH patients and controls.
  • Eight miRNAs (3 upregulated, 5 downregulated) differentiated aSAH patients from controls with high accuracy.
  • These miRNAs were specifically dysregulated in aSAH, not in other types of subarachnoid hemorrhage.
  • Two miRNAs, miR-146a-5p and miR-27b-3p, correlated with clinical outcomes.
  • Target genes of these miRNAs are involved in inflammation-related signaling pathways.

Conclusions:

  • A plasma miRNA signature for ruptured IAs was identified.
  • Eight candidate miRNAs show potential as biomarkers for ruptured IAs.
  • These differentially expressed miRNAs may play a significant role in IA pathology.